925 published test results across 147 vendors · latest: 14 Oct 2026
| # | Vendor | Tests | Price/mg | Score |
|---|---|---|---|---|
| 1 | HHK Peptides Unverified | 22 | $0.82 | 77 |
| 2 | ZZenith Jove Peptide ZJ Unverified | 10 | $0.65 | 69 |
| 3 | LLiliPeptide Unverified | 24 | $0.70 | 69 |
| 4 | HHXNet Unverified | 9 | $0.60 | 66 |
| 5 | HHkRoids Unverified | 11 | $0.94 | 66 |
| 6 | UUther Unverified | 11 | $1.00 | 65 |
| 7 | IInno Peptides Unverified | 5 | $0.60 | 64 |
| 8 | MMokemei Zhengzhou Biotechnology MKM Unverified | 5 | $0.60 | 63 |
| 9 | NNexaph | 20 | $1.52 | 63 |
| 10 | XXian Yihang Technology Unverified | 5 | — | 61 |
Computed from publicly published third-party results. How scoring works · every listing is free and un-buyable. Vendors marked Unverified appear for their published results but are left out of the vendor rankings.
BPC-157 is a synthetic 15-amino-acid peptide fragment derived from a protective protein found in gastric juice. It is one of the most searched “healing” peptides and one of the least clinically proven: virtually all of its evidence is preclinical (animal) research. It has no approved medical use anywhere.
Animal studies, largely from a single research group, report accelerated tendon, ligament, muscle, and gut healing. Peer-reviewed human trial evidence is essentially absent, a gap recent reviews in the medical literature keep pointing out. “Promising in rats” is the honest summary of the record.
BPC-157 is not FDA-approved and not lawful to market for human use. For athletes it is unambiguous: WADA prohibits BPC-157, and USADA has specifically warned athletes about it appearing in supplements. The FDA has also raised concerns about its use in compounding.
Injectable lyophilized vials dominate; capsule and “stable” oral forms are marketed for gut-focused use. Published third-party testing applies to all of them, and label-accuracy failures show up in every format.
Working out reconstitution or syringe units? Use the free peptide calculator, then check your batch’s published test result before trusting the label: vials that miss their label claims turn up regularly in Janoshik’s public results database.
Vendor rankings on PeptideCensus are computed only from publicly published third-party lab results; see the vendor index and how scoring works.
BPC-157 is most often discussed alongside TB-500 (the “wolverine stack”). That combination has its own page: BPC-157 and TB-500.
In animal research: soft-tissue and gut healing. It has no approved human use, and human trial evidence is essentially absent.
Yes: WADA prohibits it, and it is a doping-test risk for any tested athlete.
Injectable dominates the research market; oral forms are marketed for gut-focused use. Published batch testing is the quality check for both.
Unknown in humans. That is the answer the research record supports. Reported side effects are mostly anecdotal, and unverified vial contents are their own risk.
PeptideCensus aggregates publicly published third-party lab results and links every number to its source. Nothing on this page is medical advice; research compounds are not for human use.